WEI MING SUN
Pharmacy in Ann Arbor, MI
License number
Michigan 5315005855
Issued Date
Jun 24, 2001
Expiration Date
Jun 30, 2004
Category
Pharmacy
Type
CS - 1
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about WEI MING SUN at radaris.comName
Address
Phone
4969 S Ridgeside Cir, Ann Arbor, MI 48105
1106 White St, Ann Arbor, MI 48104
1326 Geddes Ave, Ann Arbor, MI 48104
1400 Townsend Dr, Houghton, MI 49931
1401 Springfield Dr, Midland, MI 48642
Professional information
See more information about WEI MING SUN at trustoria.com
Spiro-Oxindole Mdm2 Antagonists
Spiro-Oxindole Mdm2 Antagonists
US Patent:
8518984, Aug 27, 2013
Filed:
Nov 12, 2010
Appl. No.:
12/945511
Inventors:
Shaomeng Wang - Saline MI, US
Shanghai Yu - Ann Arbor MI, US
Wei Sun - Ann Arbor MI, US
Sanjeev Kumar - Ann Arbor MI, US
Duxin Sun - Ann Arbor MI, US
Peng Zou - Ann Arbor MI, US
Donna McEachern - Ann Arbor MI, US
Yujun Zhao - Ann Arbor MI, US
Shanghai Yu - Ann Arbor MI, US
Wei Sun - Ann Arbor MI, US
Sanjeev Kumar - Ann Arbor MI, US
Duxin Sun - Ann Arbor MI, US
Peng Zou - Ann Arbor MI, US
Donna McEachern - Ann Arbor MI, US
Yujun Zhao - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07D 487/10, A61K 31/4015
US Classification:
514409, 548406
Abstract:
Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.
Spiro-Oxindole Mdm2 Antagonists
Spiro-Oxindole Mdm2 Antagonists
US Patent:
8629141, Jan 14, 2014
Filed:
May 11, 2012
Appl. No.:
13/469928
Inventors:
Shaomeng Wang - Saline MI, US
Wei Sun - Ann Arbor MI, US
Angelo Aguilar - Ann Arbor MI, US
Carlos Garcia-Echeverria - Paris, FR
Wei Sun - Ann Arbor MI, US
Angelo Aguilar - Ann Arbor MI, US
Carlos Garcia-Echeverria - Paris, FR
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
Sanofi - Paris
Sanofi - Paris
International Classification:
A61K 31/4015, C07D 209/96, C07D 273/04, C07D 401/14
US Classification:
5142328, 514278, 514409, 544 70, 546 18, 548486
Abstract:
Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.
Spiro-Oxindole Mdm2 Antagonists
Spiro-Oxindole Mdm2 Antagonists
US Patent:
2012012, May 17, 2012
Filed:
Nov 11, 2011
Appl. No.:
13/294315
Inventors:
Shaomeng Wang - Saline MI, US
Yujun Zhao - Ann Arbor MI, US
Wei Sun - Ann Arbor MI, US
Sanjeev Kumar - Ann Arbor MI, US
Lance Leopold - Dresher PA, US
Laurent Debussche - Paris, FR
Cedric Barriere - Paris, FR
Jean-Christophe Carry - Paris, FR
Kwame Amaning - Paris, FR
Yujun Zhao - Ann Arbor MI, US
Wei Sun - Ann Arbor MI, US
Sanjeev Kumar - Ann Arbor MI, US
Lance Leopold - Dresher PA, US
Laurent Debussche - Paris, FR
Cedric Barriere - Paris, FR
Jean-Christophe Carry - Paris, FR
Kwame Amaning - Paris, FR
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
SANOFI - Paris
ASCENTA THERAPEUTICS, INC. - Malvern PA
SANOFI - Paris
ASCENTA THERAPEUTICS, INC. - Malvern PA
International Classification:
A61K 31/407, A61P 35/00, A61P 35/02, C07D 487/10
US Classification:
514409, 548410
Abstract:
Provided herein are compounds, compositions, and methods in the field of medicinal chemistry. The compounds and compositions provided herein relate to spiro-oxindoles which function as antagonists of the interaction between p53 and MDM2, and their use as therapeutics for the treatment of cancer and other diseases.